Effects of methotrexate on plasma cytokines and cardiac remodeling and function in postmyocarditis rats

Mediators of Inflammation

Volumn 2009, Issue , 2009, Pages

  Zhang, Zhengang ^a,b,c   Zhao, Pei ^a   Li, Aihua ^a   Lv, Xiaolei ^a   Gao, Yang ^a   Sun, Hongguang ^a   Ding, Yongling ^a   Liu, Jian ^a  

^a Medical College of Southeast University   (China)

^b YANGZHOU UNIVERSITY   (China)

^c SOUTHEAST UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN; COLLAGEN TYPE 1; COLLAGEN TYPE 3; CYTOKINE; INTERLEUKIN 10; INTERLEUKIN 6; METHOTREXATE; MYOSIN; SODIUM CHLORIDE; TUMOR NECROSIS FACTOR ALPHA; IMMUNOSUPPRESSIVE AGENT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARDIOMYOPATHY; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG EFFECT; HEART FUNCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE ENDDIASTOLIC PRESSURE; HEART MUSCLE FIBROSIS; HEART PROTECTION; HEART VENTRICLE REMODELING; INFLAMMATION; LOW DRUG DOSE; MALE; MYOCARDITIS; NONHUMAN; PRIORITY JOURNAL; RAT; REGULATORY MECHANISM; ANIMAL; BLOOD; DISEASE MODEL; HEART; LEWIS RAT; SWINE;

RATTUS;

ANIMALS; COLLAGEN TYPE I; COLLAGEN TYPE III; CYTOKINES; DISEASE MODELS, ANIMAL; HEART; IMMUNOSUPPRESSIVE AGENTS; INTERLEUKIN-10; INTERLEUKIN-6; MALE; METHOTREXATE; MYOCARDITIS; RATS; RATS, INBRED LEW; SWINE; TUMOR NECROSIS FACTOR-ALPHA; VENTRICULAR REMODELING;

EID: 70449412259     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2009/389720     Document Type: Article

References (26)

1. Mosterd A., Hoes A. W., Clinical epidemiology of heart failure Heart 2007 93 9 1137 1146
2. Gong K. Z., Song G., Spiers J. P., Kelso E. J., Zhang Z. G., Activation of immune and inflammatory systems in chronic heart failure: novel therapeutic approaches International Journal of Clinical Practice 2007 61 4 611 621
3. Jankowska E. A., Ponikowski P., Piepoli M. F., Banasiak W., Anker S. D., Poole-Wilson P. A., Autonomic imbalance and immune activation in chronic heart failure-pathophysiological links Cardiovascular Research 2006 70 3 434 445
4. Blum A., Miller H., Pathophysiological role of cytokines in congestive heart failure Annual Review of Medicine 2001 52 15 27
5. Valgimigli M., Ceconi C., Malagutti P., Tumor necrosis factor- receptor 1 is a major predictor of mortality and new-onset heart failure in patients with acute myocardial infarction: the cytokine-activation and long-term prognosis in myocardial infarction (C-ALPHA) study Circulation 2005 111 7 863 870
6. Sivasubramanian N., Coker M. L., Kurrelmeyer K. M., Left ventricular remodeling in transgenic mice with cardiac restricted overexpression of tumor necrosis factor Circulation 2001 104 7 826 831
7. Faircloth M., Clark J., Dighe K., Marber M., The effects of chronic TNF- administration in C57/BL6 mice Heart 2006 92 supplement 2. pA71
8. Wolfe F., Michaud K., Heart failure in rheumatoid arthritis: rates, predictors, and the effect of anti-tumor necrosis factor therapy The American Journal of Medicine 2004 116 5 305 311 (Pubitemid 38230289)
9. Nishio R., Matsumori A., Shioi T., Ishida H., Sasayama S., Treatment of experimental viral myocarditis with interleukin-10 Circulation 1999 100 10 1102 1108
10. Bolger A. P., Sharma R., von Haehling S., Effect of interleukin-10 on the production of tumor necrosis factor-alpha by peripheral blood mononuclear cells from patients with chronic heart failure The American Journal of Cardiology 2002 90 4 384 389 (Pubitemid 34895058)
11. Stumpf C., Lehner C., Yilmaz A., Daniel W. G., Garlichs C. D., Decrease of serum levels of the anti-inflammatory cytokine interleukin-10 in patients with advanced chronic heart failure Clinical Science 2003 105 1 45 50
12. Prabhu S. D., Chandrasekar B., Murray D. R., Freeman G. L., -adrenergic blockade in developing heart failure: effects on myocardial inflammatory cytokines, nitric oxide, and remodeling Circulation 2000 101 17 2103 2109
13. Dolhain R. J. E. M., Tak P. P., Dijkmans B. A. C., De Kuiper P., Breedveld F. C., Miltenburg A. M. M., Methotrexate reduces inflammatory cell numbers, expression of monokines and of adhesion molecules in synovial tissue of patients with rheumatoid arthritis British Journal of Rheumatology 1998 37 5 502 508
14. Furst D. E., The rational use of methotrexate in rheumatoid arthritis and other rheumatic diseases British Journal of Rheumatology 1997 36 11 1196 1204
15. Yuan Z., Kishimoto C., Shioji K., Nakamura H., Yodoi J., Sasayama S., Temocapril treatment ameliorates autoimmune myocarditis associated with enhanced cardiomyocyte thioredoxin expression Cardiovascular Research 2002 55 2 320 328
16. Genestier L., Paillot R., Fournel S., Ferraro C., Miossec P., Revillard J.-P., Immunosuppressive properties of methotrexate: apoptosis and clonal deletion of activated peripheral T cells The Journal of Clinical Investigation 1998 102 2 322 328
17. Devereux R. B., Reichek N., Echocardiographic determination of left ventricular mass in man. Anatomic validation of the method Circulation 1977 55 4 613 618
18. Nagaya N., Kangawa K., Itoh T., Transplantation of mesenchymal stem cells improves cardiac function in a rat model of dilated cardiomyopathy Circulation 2005 112 8 1128 1135
19. Yokoseki O., Suzuki J.-I., Kitabayashi H., Cis element decoy against nuclear factor- B attenuates development of experimental autoimmune myocarditis in rats Circulation Research 2001 89 10 899 906
20. Futamatsu H., Suzuki J., Koga N., A CCR1 antagonist prevents the development of experimental autoimmune myocarditis in association with T cell inactivation Journal of Molecular and Cellular Cardiology 2006 40 6 853 861
21. Gong K., Zhang Z., Sun X., The nonspecific anti-inflammatory therapy with methotrexate for patients with chronic heart failure American Heart Journal 2006 151 1 62 68
22. Pathak M., Sarkar S., Vellaichamy E., Sen S., Role of myocytes in myocardial collagen production Hypertension 2001 37 3 833 840
23. Liu W., Li W.-M., Gao C., Sun N.-L., Effects of atorvastatin on the Th1/Th2 polarization of ongoing experimental autoimmune myocarditis in Lewis rats Journal of Autoimmunity 2005 25 4 258 263
24. Krishnamurthy P., Rajasingh J., Lambers E., Qin G., Losordo D. W., Kishore R., IL-10 inhibits inflammation and attenuates left ventricular remodeling after myocardial infarction via activation of STAT3 and suppression of HuR Circulation Research 2009 104 2 e9 e18
25. Dalmarco E. M., Frde T. S., Medeiros Y. S., Effects of methotrexate upon inflammatory parameters induced by carrageenan in the mouse model of pleurisy Mediators of Inflammation 2002 11 5 299 306
26. Johnston A., Gudjonsson J. E., Sigmundsdottir H., Ludviksson B. R., Valdimarsson H., The anti-inflammatory action of methotrexate is not mediated by lymphocyte apoptosis, but by the suppression of activation and adhesion molecules Clinical Immunology 2005 114 2 154 163, 2005